Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

NDORMS Professor of Medical Statistics and Director of the Centre for Statistics in Medicine, Gary Collins has been appointed National Institute of Health Research (NIHR) Senior Investigator.

Gary Collins

NIHR Senior Investigators are among the most prominent and prestigious researchers funded by the NIHR. They are outstanding leaders in their fields and are important NIHR ambassadors, contributing to the development of the next generation of health researchers.

"Receiving the NIHR Senior Investigator award is a personal honour that reflects years of commitment. As a medical statistician focussed on improving the design, analysis and transparent reporting of healthcare research, so that it has value to patients and the wider society, I am particularly thrilled to be recognised." says Professor Gary Collins.

He adds: "I believe the credit extends far beyond myself. I am incredibly grateful to everyone who has been with me on this journey, including those already holding this distinction within NDORMS, the University and beyond – but most of all to my team and collaborators. The NIHR is a fantastic organisation, and this prestigious award fuels my motivation to continue carrying out leading healthcare research. I look forward to contributing to the NIHR as a senior leader and acting as an ambassador for the NIHR."

NIHR Senior Investigators receive a discretionary award of £20,000 a year to fund activities that support their research and the  awards are four years in duration.

Supported by

NIHR Logo

Similar stories

Study challenges fears over blood-clot risk from painkillers and hormonal contraception

Women using hormonal contraception who are prescribed common anti-inflammatory painkillers may not face a drug-related increase in blood-clot risk despite previous research, according to a new DARWIN EU® study.

First clinical study in GSK-Oxford Experimental Medicine Collaboration starts as first patient dosed in ulcerative colitis experimental trial

The first patient in the PEGASUS clinical study, part of the GSK-University of Oxford Experimental Medicine Collaboration, received the first dose last week, on 8th October 2026.

Adam Croft appointed Norman Collisson Professor of Musculoskeletal Science

This appointment brings a further focus to linking rheumatology discovery science and clinical trials in NDORMS, strengthening translational rheumatology research across the department to deliver transformative treatments for patients with inflammatory arthritis.

NIHR fellowship to support national trial evaluating rehabilitation after kneecap dislocation

Dr Colin Forde has been awarded a National Institute for Health and Care Research (NIHR) Health Technology Assessment (HTA) Postdoctoral Award to lead a national study evaluating rehabilitation for people with a kneecap (patellar) dislocation.

Robotic hip and knee surgery fails to cut overall risk of repeat surgery

Two major studies from the University of Oxford, Queen Mary University of London and the University of Bristol, have found that robotic-assisted hip and knee replacement does not reduce the overall early risk of repeat surgery compared with conventional surgery.

Professor Afsie Sabokbar retires after more than 30 years at NDORMS

Botnar Institute Director of Graduate Studies, Professor Afsie Sabokbar, is retiring after more than 30 years at NDORMS.